These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia? Humphries SE; Norbury G; Leigh S; Hadfield SG; Nair D Curr Opin Lipidol; 2008 Aug; 19(4):362-8. PubMed ID: 18607183 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia. Futema M; Bourbon M; Williams M; Humphries SE Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085 [TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales. Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685 [TBL] [Abstract][Full Text] [Related]
7. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. Wald DS; Wald NJ J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009 [TBL] [Abstract][Full Text] [Related]
8. Parental attitude towards genetic testing for familial hypercholesterolaemia in children. Umans-Eckenhausen MA; Oort FJ; Ferenschild KC; Defesche JC; Kastelein JJ; de Haes JC J Med Genet; 2002 Sep; 39(9):e49. PubMed ID: 12205119 [No Abstract] [Full Text] [Related]
9. Guidelines for the diagnosis and management of familial hypercholesterolaemia. Sullivan D; Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936 [No Abstract] [Full Text] [Related]
10. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use? Paynter NP; Ridker PM; Chasman DI Circ Res; 2016 Feb; 118(4):607-19. PubMed ID: 26892961 [TBL] [Abstract][Full Text] [Related]
12. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel. Stock J Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168 [No Abstract] [Full Text] [Related]
13. Mutation screening in patients for familial hypercholesterolaemia (ADH). Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101 [No Abstract] [Full Text] [Related]
14. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania. Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078 [TBL] [Abstract][Full Text] [Related]
15. Rapid testing for three mutations causing familial defective apolipoprotein B100 in 562 patients with familial hypercholesterolaemia. Talmud PJ; Tamplin OJ; Heath K; Gaffney D; Day IN; Humphries SE Atherosclerosis; 1996 Aug; 125(1):135-7. PubMed ID: 8831935 [No Abstract] [Full Text] [Related]
17. People at risk of familial hypercholesterolaemia should have DNA test, says NICE. BMJ; 2017 Nov; 359():j5112. PubMed ID: 29097374 [No Abstract] [Full Text] [Related]
18. Genetic testing for a patient with suspected familial hypercholesterolaemia. Mudgundi V; Williams G; Manou K; Block R BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30030251 [TBL] [Abstract][Full Text] [Related]
19. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482 [TBL] [Abstract][Full Text] [Related]
20. [A family-based strategy for diagnosing familial hypercholesterolemia]. Leren TP; Manshaus T; Ose L Tidsskr Nor Laegeforen; 2004 May; 124(9):1228-9. PubMed ID: 15131703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]